

























































published: 05 November 2014
doi: 10.3389/fimmu.2014.00527
Priming of CD8+ T cell responses to liver stage malaria
parasite antigens
Giampietro Corradin1* and Jelena Levitskaya2
1 Biochemistry Department, University of Lausanne, Epalinges, Switzerland
2 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Edited by:
Ute Frevert, NewYork University
School of Medicine, USA
Reviewed by:
John Harty, University of Iowa, USA
Denise Doolan, Queensland Institute
of Medical Research, Australia
Dominique Mazier, University Pierre
and Marie Curie, France
*Correspondence:
Giampietro Corradin, Biochemistry
Department, University of Lausanne,
Chemin des Boveresses 157, 1066
Epalinges, Switzerland
e-mail: giampietro.corradin@unil.ch
While the role of malaria parasite-specific memory CD8+ T cells in the control of exo-
erythrocytic stages of malaria infection is well documented and generally accepted, a
debate is still ongoing regarding both the identity of the anatomic site where the activation
of naive pathogen-specific T cells is taking place and contribution of different antigen-
presenting cells (APCs) into this process.Whereas some studies infer a role of professional
APCs present in the lymph nodes draining the site of parasite injection by the mosquito,
others argue in favor of the liver as a primary organ and hepatocytes as stimulators of
naïve parasite-specific T cell responses. This review aims to critically analyze the current
knowledge and outline new lines of research necessary to understand the induction of
protective cellular immunity against the malaria parasite.
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INTRODUCTION
It is currently accepted that priming of CD8+ T lymphocytes
by antigen-presenting cells (APCs) takes place in the secondary
lymphoid organs such as spleen and lymph nodes [reviewed in
Ref. (1)]. Multi-photon-based intravital microscopy revealed that
the first contact between naïve CD8+ T cells and APC takes
place in the periphery of draining lymph nodes (DLN) shortly
after infection and mainly occurs in the subcapsular sinus or the
interfollicular regions enriched with pathogen-derived antigens
(2, 3). Depending on the pathogen’s nature, the rapid reloca-
tion of naïve T cells to the periphery of the draining lymph
node can be either antigen-specific (2) or antigen-independent,
associated with decreased local levels of chemokines and the dras-
tic alteration of the lymph node architecture by the pathogen
(3, 4). Data from mice infected with vesicular stomatitis virus
demonstrated that, though CD169+ macrophages (5) residing
in the subcapsular sinus were the major cell population bearing
virus-derived antigens (2), dendritic cells (DCs) served as the pri-
mary APC triggering antigen-specific naïve CD8+ T cells. The
ability of immature dendritic cells to acquire exogenous anti-
gens followed by their proteolytic processing and presentation
on the MHC class I molecules, commonly referred to as “cross-
presentation,” is believed to be the major requirement for the
generation of primary antigen-specific CD8+ T cell responses
against pathogens (6–9).
Upon the initial encounter of naïve T cells with APC, a het-
erogeneous progeny of antigen-specific CD8+ T cells including
short-lived effector cells (SLEC) and memory precursor effec-
tor cells (MPEC) [reviewed in Ref. (10, 11)] is generated. It is
still not clear whether the SLEC versus MPEC differentiation is
enforced by the asymmetric segregation of transcription factors
and protein degradation machinery already at the first cell divi-
sion (12–14) or it reflects the differential exposure to inflammatory
and co-stimulatory “help” signals received from APCs by antigen-
specific CD8+ T cells during the expansion phase [reviewed in
Ref. (10, 11)]. While generation of primary CD8+ T cell responses
to non-inflammatory antigens requires CD4+ T cell help, induc-
tion of primary CD8+ T cells responses to Listeria, LCMV, and
influenza virus is CD4+ T cell-independent and results from direct
activation of APCs by the pathogen (15–17). Moreover, CD4+ T
cell help can be replaced by the CD40 triggering on the DCs, which
prime antigen-specific naïve CD8+ T cells (18, 19). Thus, the exact
nature and requirements for “help” signals necessary for the initial
triggering and subsequent expansion of primary antigen-specific
CD8+ T cell responses vary among different pathogens and sites
of primary infection. In this report, our objective is to present
and discuss the published data regarding CD8+ T cell activa-
tion in Plasmodium infection, and suggest experiments to better
understand the antigen presentation process.
Malaria infection is initiated through the bites by Plasmod-
ium-carrying female Anopheles searching for blood to support
egg development. As the mosquito probes the host environment
under the skin for the presence of blood vessels, it injects sali-
vary gland proteins both prior and during blood feeding to inhibit
blood coagulation. Parasites deposited into the skin can also tra-
verse surrounding cells and enter the circulation with subsequent
infection of liver cells. Studies performed with parasites injected
intradermally or intravenously show that the resulting liver para-
site load is similar (20). In addition, transfer of parasites from the
skin sites to DLN occurs (21).
Identification of the anatomical site and the type of APC,
which orchestrate the induction of primary CD8+ T cell responses
against a particular antigen, represents an essential step in rational
design of CD8+ T cell-based vaccination strategies. Whereas the
research on the effector phase of CD8+ T cell response against
malaria has been quite extensive (22–25), a rather limited number
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of studies attempted to dissect the issue of liver stage-specific
CD8+ T cell priming in the infected host.
ROLE OF DIFFERENT ORGANS IN ANTIGEN PRESENTATION
In this respect, the study by Chakravarty et al. (21) appears to
be one of the most comprehensive and systematic up to date.
The authors concluded that extrahepatic lymphoid tissues, in
particular the DLN and spleen are the most important sites con-
tributing to the generation of the effector T-cell pool in the liver.
In agreement with these data, Obeid and colleagues demonstrated
that strictly subcutaneous immunization with irradiated sporo-
zoites led to induction of sterile immunity against pre-erythrocytic
malaria with T cell priming occurring in skin-draining lymph
node (26). It was proposed that parasite-specific CD8+ T cell
priming depends on cross-presentation of malaria antigens (21).
This indicates that professional APC, rather than infected hepato-
cytes, trigger priming of naïve CD8+ T cells directed to liver stage
antigens.
Several lines of experimental evidence were presented in sup-
port of these conclusions. Thus, IFNγ production by adoptively
transferred circumsporozoite protein (CSP)-specific naïve trans-
genic T cells was first detected in the skin-DLN as early as on day
2 after mouse immunization by microinjection or mosquito bites,
whereas no detectable T cell activation was detected in other organs
including spleen. Hence, Chakravarty and co-authors suggested
that these temporal differences in the onset of parasite-specific T
cell activation could reflect the hierarchical order of T cell prim-
ing initiated in the DLN that could be followed by migration of
primed CD8+ T cells to other organs, including the spleen and the
liver. However, removal of lymph nodes draining the site of par-
asite injection prior to the adoptive transfer of parasite-specific
CD8+ T cells, though resulted in a 60% reduction of activated
CD8+ T cells in the liver, did not affect the frequencies of primed
CD8+ T cells in the spleen where the first signs of T cells acti-
vation were documented only 24 h later than in DLN and at the
same time point as in the liver. These data indicate that temporal
differences in the onset of T cell activation used as a parameter for
identification of the CD8+ T cell priming site should be carefully
reconsidered in future studies and further strengthen the impor-
tance of the spleen as a site of induction of primary CD8+ T cell
responses in animal models of the infection. The latter is in agree-
ment with the data by Sano et al. (27) demonstrating that spleens
of infected mice support priming of parasite-specific naïve CD8+
T cells following intravenous injection of sporozoites.
At the same time, several lines of evidence presented by
Chakravarty and colleagues (21) do not firmly support the essen-
tial role of the spleen in the parasite-specific CD8+ T cell
priming.
First, DCs isolated from the spleens 60 h after injection of
sporozoites were unable to trigger proliferation of parasite-specific
CD8+ T cells, whereas DCs isolated from the DLN efficiently
induced T cell proliferation and, presumably, presented the anti-
gen. Since no data with liver-resident DCs were generated, a direct
role of intrahepatic professional APCs in priming of parasite-
specific CD8+ T cells still needs to be addressed. In addition, as
the first signs of activation of parasite-specific T cells in DLN were
detected at day 2 post immunization, it is not completely clear
whether DCs from DLN had a greater capacity to prime CD8+ T
cells as compared to spleen and liver-resident DCs at time points
earlier than 60 h.
Second, animals subjected to simultaneous lymphadenectomy
and splenectomy prior to the adoptive transfer of CSP-specific
CD8+ T cells followed by immunization with sporozoites and sub-
sequent challenge with viable parasites 10 days later had similar
load of parasites in the liver as non-immunized mice, indicat-
ing that either DLN or/and spleen are required for CSP-specific
CD8+ T cell priming. At the same time, splenectomy alone did
not affect inhibition of parasite development in the liver, prompt-
ing the authors to conclude, that DLNs are the priming site of
protective CD8+ T cell responses.
Interestingly, as shown by Chakravarty and co-authors (21),
removal of both DLNs and the spleen prior to immunization with
sporozoites, though drastically reduced the activated T cell pool
in the liver, failed to abrogate it completely, suggesting that at least
a proportion of parasite-specific CD8+ T cells found in the liver
had been primed outside the DLN and the spleen. These findings
could reflect the process of parasite-specific CD8+ T cell trigger-
ing in the liver and define it as the organ essential for the parasite
development. On the other hand, animals treated with FTY720,
a drug, which inhibits lymphocyte egress from lymph nodes (28,
29), had substantially less IFN gamma producing parasite-specific
CD8+ T cells at day 7 post injection with irradiated sporozoites.
Based on this observation, the authors concluded that systemic
distribution of CD8+ T cells, at least in part, contributes to the
intrahepatic pool of parasite-specific CD8+ T cells (21). It still
needs to be seen, if treatment with FTY720 (30) inhibits the devel-
opment of “early-primed” parasite-specific CD8+ T cells in the
liver and spleen, previously noted by the authors already 72 h after
mosquito bite. In addition, effect of FTY720 on the protection
of animals from subsequent challenge with live sporozoites has
to be addressed in this model. Noteworthy, the time course of
the parasite-specific clonal T cell activation in the lymph nodes,
liver, and other organs is only slightly delayed (by 24 h) while it is
known that activated T cells egress from the lymph nodes 4–5 days
after antigen encounter (31, 32). The latter suggests that either
activation of parasite-specific T cells may take place simultane-
ously in various organs, or unusually rapid egress from the lymph
node after priming is an intrinsic feature of T cells in this specific
experimental model.
ROLE OF INFECTED HEPATOCYTES IN ANTIGEN
PRESENTATION
The role of infected hepatocytes in direct priming of naïve parasite-
specific CD8+ T cells is still a subject of controversy. Early study
by Renia et al. demonstrated that intrasplenic injection of infected
hepatocytes induced protective T cell-mediated immunity against
infection with Plasmodium yoelii and P. berghei sporozoites (33).
Leiriao et al. demonstrated that apoptotic hepatocytes infected
with irradiated sporozoites are phagocytosed by DCs and merely
serve as a source of Plasmodium antigens for the initiation of
the protective immune responses via cross-priming (34). In con-
trast, Renia and collaborators argued against apoptotic infected
hepatocytes as a source of antigens and suggested that liver DCs
could be activated upon uptake of parasite antigens directly from

























































Corradin and Levitskaya CTL priming by malaria antigens
viable infected hepatocytes (35) as previously seen in other exper-
imental models (36, 37). However, data from Chakravarty et al.
implied that though cross-priming is required, it takes place in the
DLNs and not in the liver (21). In agreement with these data, Jung
et al. demonstrated that mice subjected to chemical depletion of
CD11c+ DCs fail to induce CD8+ T cell responses to infection
with Plasmodium yoelii (38). Neither of these studies considered
hepatocytes as an APC subset capable of initiating the primary
parasite-specific T cell responses.
A recent study by Balam et al. (39) focused on two questions:
can infected hepatocytes directly prime naïve parasite-specific T
cells and does stimulation of already primed CD8+ T cells protect
mice against parasite challenge? Administration of CD8+ CSP-
specific T cells but not an irrelevant T cell clone injected into
TAP-deficient MHC class I mismatched recipient mice, simulta-
neously with infected hepatocytes bearing MHC haplotype rele-
vant for parasite-specific T cells, resulted in 100% protection of
mice from subsequent challenge with live sporozoites (39). As the
observed protection was not due to a bystander effect or a contin-
uous cytokine secretion by parasite-specific CD8+ T cells, these
data demonstrate that infected hepatocytes are capable of present-
ing the antigen to CD8+ T cells, reactivating resting CSP-specific
CD8+ T cells and inducing protection.
Importantly, more than 60% of naïve BALB/c mice injected
with irradiated sporozoite-infected hepatocytes were also pro-
tected from subsequent live parasite challenge, suggesting that
infected hepatocytes could contribute to the priming of endoge-
nous naïve T cell. However, T cell depletion experiments are
required to confirm that protection is T cell-mediated. Finally,
to formally exclude contamination with other APC potentially
present in the hepatocyte preparations and capable of present-
ing CSP and priming the naïve CD8+ T cells, isolation of pure
hepatocyte population devoid of cells bearing markers of DCs,
macrophages, and stellate cells should be done by flow cytom-
etry using fluorescent transgenic parasites. On the other hand,
arguing against the sole role of professional APC in priming of
naïve immune responses to malaria parasites, mice depleted of
DCs by treatment with cytochrome c were still protected from
the challenge with live sporozoites in spite of significantly lower
frequencies of endogenous parasite-specific T cells primed by the
immunization with irradiated sporozoites (39). These data do not
fully support the previously discussed role of dendritic cell func-
tion in induction of primary malaria liver stage-specific T cell
responses (21, 38).
OTHER CONSIDERATIONS
The quality of hepatocytes as APCs capable of triggering T cells
responses had been recently dissected by Ma et al. (40). It had been
demonstrated that P. berghei and P. falciparum infected human
hepatocytes retain largely unaltered expression of multiple mole-
cules of the MHC class I pathway until very late stages of parasite
development (40). Moreover, infected cells exhibited no obvious
defects in the capacity to upregulate expression of different mol-
ecular components of the MHC class I machinery in response
to pro-inflammatory lymphokines or trigger direct activation of
allo-specific as well as peptide-specific human CD8+ T cells (40).
At the same time, it is not known whether or not the characteristic
features of professional APC believed to be important for effi-
cient T-cell priming, i.e., co-stimulatory molecules B7.1 and B7.2
(“signal 2”), as well as production of cytokines essential for the
survival and maintenance of primed T cells (“signal 3”) are pos-
sessed by the primary human hepatocytes in vivo and/or induced
upon infection.
Current literature dissecting the ability of primary hepatocytes
to specifically prime naïve CD8+ T cells is scarce. Bertolino et al.
demonstrated that purified primary murine hepatocytes were able
to induce activation and proliferation of antigen-specific naive
CD8+ T cells in vitro, even in the absence of exogenously added
cytokines as well as CD80 and CD86 co-stimulatory molecules
(41). Moreover, the magnitude of T cell proliferation induced
by primary hepatocytes was comparable to that induced by DCs.
Naïve T cell priming by hepatocytes did not require CD4+ T cell
help and induced expression of early T cell activation markers
and transient CD8+ T cell effector activity followed by rapid cell
death of activated T cells. Thus, primary hepatocytes were able
to prime naïve T cells but failed to sustain productive antigen-
specific CD8+ T cell responses (41). In agreement with these data,
in vivo experiments using endogenous expression of alloantigens
under hepatocyte-specific promoters demonstrated that activa-
tion of primary T cells by hepatocytes as antigen-presenting cells
leads to T cell apoptosis rather than formation of antigen-specific
memory T cell pool (42–44). It was further demonstrated that T
cells activated by hepatocytes died “by neglect” and lack of IL-2
and low expression of pro-survival genes due to insufficient co-
stimulation during the priming phase (45). Hence, taking into
account the inability of primary hepatocytes to provide appropri-
ate co-stimulation during T cells priming along with the immuno-
suppressive microenvironment created by multiple subsets of the
liver-resident APC [reviewed in Ref. (46, 47)], it may appear
unlikely that hepatocytes infected with malaria parasites play a
major role in the generation of effective parasite-specific CD8+ T
cell memory responses. However, it does not preclude the possibil-
ity that CD8+ T cells specific to malaria antigens could be primed
and activated, at least shortly, by hepatocytes supporting devel-
opment of exo-erythrocytic forms. Indeed, given proper stimuli,
such T cells can be rescued to full immunological competence
and longer survival (48, 49). In the case of malaria, proper acti-
vation stimuli could be induced by Plasmodium infection leading
to activation of numerous genes in hepatocytes (50, 51) including
those involved in native immunity and antigen presentation. Since
no transcriptional analysis has been performed in Kupffer cells
traversed by sporozoites so far, it would be important to under-
stand whether or not liver-resident macrophages change their
immunomodulatory properties in the site of malaria infection.
At this point, a word of caution should be expressed to the
fact that all animal studies discussed above were based on a
single mouse strain, BALB/c, as well as a single CD8+ T cell epi-
tope derived from the CSP. Future studies on the induction of
primary T cell responses to exo-erythrocytic forms of malaria
need to be extended to other protective CD8+ T cell epitopes
including responses, which appear later in the liver stage by
using either radiation attenuated (RAS) or genetically attenuated
(GAS) sporozoites or sporozoites combined with chloroquine
chemoprophylaxis (CPS) (52).
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FIELD STUDIES
It is still unclear to what extend animal models dissecting induc-
tion of primary T cell responses to malaria as well as human studies
involving vaccinated volunteers reflect the acquisition of natural
cellular immune responses in malaria endemic areas. An acquisi-
tion of a sterile immune protection following immunization with
RAS, GAS, or using CPS regime in animals and humans sharply
contrasts with the situation in the field, where, in spite of fre-
quent (up to 30 per month in certain areas) biting by infected
mosquitoes (53, 54), no sterile protection is usually obtained in
both adults and children in response to natural infection under
drug treatment or intermittent preventive treatment (IPT). Sev-
eral hypotheses could be proposed to explain this discrepancy: (1)
sporozoite “charge” (and, as a result, supply of parasite antigens) is
too small in the field as compared to that given under experimen-
tal conditions; (2) down-regulation of the parasite-specific CD8+
T cell responses by the content of mosquito salivary glands deliv-
ered together with sporozoites to the site of T cell priming; and
(3) excessive and/or preceding induction of immune responses to
salivary gland proteins. As for the latter, given the fact that only a
fraction (0–25% depending on the seasons and location) of mos-
quitoes are infected (54–56), a memory T-cell pool specific for
salivary gland antigens is most likely established prior to para-
site infection. As a result, secondary T cell responses directed to
mosquito antigens could be preferentially activated at the expense
of parasite-specific T-cell activation via, for example, competition
for IL-2, homeostatic niche, or by active secretion of inhibitory
molecules (57–64). If this is the case, the efficacy of sporozoite-
based pre-erythrocytic vaccines may turn out to be low in endemic
areas due to even subtle contamination with the salivary gland
proteins. Both the second and third hypotheses may explain the
low frequency of parasite-specific helper and CD8+ T cell found
in humans from malaria endemic regions, as well as the gen-
eral failure [with the exception for a single donor so far (65)]
to obtain stable human T-cell clones specific to malaria liver stage
antigens.
FINAL REMARKS
In conclusion, existing experimental data obtained from animal
models suggest that: (1) both DCs and hepatocytes can prime
naïve malaria parasite-specific CD8+ T cells, at least those directed
to epitopes derived from CSP and (2) either DCs or hepatocytes
are sufficient to induce protective CSP-specific T cell responses
if the parasite load is not excessive. Identification of the essen-
tial site for priming of malaria liver stage-directed CD8+ T cell
responses of broader antigen specificity as well as mimicking the
conditions of the natural exposure to the uninfected mosquito
vector will pave the way for the optimal design of T cell-based
vaccines. We hope that experimental approaches suggested above
in the context of the reviewed original data (21, 27, 34, 39) will
prompt further studies on the induction and maintenance of pro-
tective T cell responses against exo-erythrocytic stages of malaria
infection.
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